Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Michael, Samarkos"'
Publikováno v:
Antibiotics, Vol 13, Iss 11, p 1082 (2024)
Background/objectives: Blood culture (BC) contamination is a frequent problem which leads to increased laboratory workload, inappropriate use of antibiotics and the associated adverse events, and increased healthcare costs. This study prospectively e
Externí odkaz:
https://doaj.org/article/5625e0bc0d7543f8bde2b6122bad0022
Autor:
Vasiliki Rapti, Garyfallia Poulakou, Anastasia Mousouli, Athanasios Kakasis, Stamata Pagoni, Evmorfia Pechlivanidou, Aikaterini Masgala, Styliani Sympardi, Vasileios Apostolopoulos, Charalampos Giannopoulos, Nikolaos Alexiou, Kostoula Arvaniti, Christina Trakatelli, Apostolos Prionas, Michael Samarkos, George L. Daikos, Helen Giamarellou
Publikováno v:
Antibiotics, Vol 13, Iss 9, p 812 (2024)
Antimicrobial resistance poses a major threat to human health worldwide and the implementation of antimicrobial stewardship programs (ASPs), including antimicrobial de-escalation (ADE), is a multifaceted tool for minimizing unnecessary or inappropria
Externí odkaz:
https://doaj.org/article/6d9be285b92a4844810f0979dd97c1d1
Publikováno v:
Antibiotics, Vol 13, Iss 4, p 329 (2024)
Antimicrobial resistance (AMR) has emerged as one of the leading public health threats of the 21st century. New evidence underscores its significance in patients’ morbidity and mortality, length of stay, as well as healthcare costs. Globally, the f
Externí odkaz:
https://doaj.org/article/2121a74e82de4e9387215d4587d3c8fa
Autor:
Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101785- (2023)
Summary: Background: The SAVE-MORE trial demonstrated that anakinra treatment in COVID-19 pneumonia with plasma soluble urokinase plasminogen activator (suPAR) levels of 6 ng/mL or more was associated with 0.36 odds for a worse outcome compared to pl
Externí odkaz:
https://doaj.org/article/849b622a96a44a189757b8aa960d5cf4
Autor:
Sofia Kostourou, Ilias Samiotis, Panagiotis Dedeilias, Christos Charitos, Vasileios Papastamopoulos, Dimitrios Mantas, Mina Psichogiou, Michael Samarkos
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1182 (2023)
In our hospital, adherence to the guidelines for peri-operative antimicrobial prophylaxis (PAP) is suboptimal, with overly long courses being common. This practice does not offer any incremental benefit, and it only adds to the burden of antimicrobia
Externí odkaz:
https://doaj.org/article/7af962419ee5490fb5612df28f5251f9
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Immune checkpoint inhibitors (ICBs) have revolutionized cancer treatment producing remarkable and durable responses for a range of malignancies. However, the additional modulation of immune response by ICBs may rarely cause immune-related in
Externí odkaz:
https://doaj.org/article/7067f65aea87429b918e45dbcd47f0bb
Autor:
Michael Samarkos, Konstantinos Papanikolaou, Athena Sourdi, Nikolaos Paisios, Efstratios Mainas, Elisabeth Paramythiotou, Anastasia Antoniadou, Helen Sambatakou, Panayiotis Gargalianos-Kakolyris, Athanasios Skoutelis, George L. Daikos
Publikováno v:
Antibiotics, Vol 11, Iss 8, p 1066 (2022)
(1) Background: It is not known whether different daily dosing schemes have different effects on colistin nephrotoxicity. We examined the effect of once- versus twice- or thrice-daily doses of colistin on renal function. (2) Methods: We performed a m
Externí odkaz:
https://doaj.org/article/49cabdac6eca4b0bac90b4311fd26575
Autor:
Maria Liodaki, Emmanouil Angelakis, Gregory Spanakos, Ioanna Papadogiannaki, Michael Samarkos, George L. Daikos, Barbara Christopoulou, Evangelia-Theophano Piperaki
Publikováno v:
Zoonotic Diseases; Volume 2; Issue 4; Pages: 247-257
The bacteria of the families Rickettsiaceae and Anaplasmataceae, harbored by arthropod vectors, may cause disease in animals and humans. The aim of this study was to screen ectoparasites collected from cats and dogs in Attica, Greece for the bacteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b44befcff642c502575aca207af1a95
https://doi.org/10.3390/zoonoticdis2040020
https://doi.org/10.3390/zoonoticdis2040020
Autor:
Chrysanthe Papafotiou, Sotirios Roussos, Vana Sypsa, Sofia Bampali, Kalliopi Spyridopoulou, Amalia Karapanou, Anastasia Moussouli, Michael Samarkos, George L Daikos, Mina Psichogiou
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:3331-3339
Objectives Carbapenemase-producing Enterobacterales (CPE) comprise important nosocomial pathogens worldwide. Colonized patients are the source of further dissemination in healthcare settings. Considering that timely detection of CPE carriers is pivot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f9b82aa622a44ba6039a326612a579
https://doi.org/10.1093/jac/dkac321
https://doi.org/10.1093/jac/dkac321
Autor:
Charalampos Theocharopoulos, Panagiotis-Petros Lialios, Michael Samarkos, Helen Gogas, Dimitrios C. Ziogas
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1111 (2021)
In the era of precision medicine, antibody-based therapeutics are rapidly enriched with emerging advances and new proof-of-concept formats. In this context, antibody-drug conjugates (ADCs) have evolved to merge the high selectivity and specificity of
Externí odkaz:
https://doaj.org/article/ba7cd38f77ea4666a0fb97b6efb606d7